Kettering Medical Center has realized a positive financial impact of $3.7 million in the past year as the result of a change in standard operating procedures using a new innovative testing technology that diagnoses a wide variety of infectious diseases faster and more accurately than traditional testing.
"This unique diagnostic technology allows us to diagnose patients faster, and the faster we can provide treatment the faster our patients heal," said Carol Quinter, PhD, Director of Kettering Laboratory Clinical Services and Technical Director of DIATHERIX Laboratory at Kettering Medical Center. "This technology, developed by DIATHERIX Laboratories, is a game changer for the healthcare industry. Hospital savings are directly tied to reducing patient infection rates, decreasing the days patients need to be kept in isolation and prescribing fewer antibiotics."
In 2010, Kettering Medical Center partnered with DIATHERIX Laboratories and together the two organizations established the only on-site hospital laboratory in the country utilizing the diagnostic technology called TEM-PCR.
"When we began our partnership with Kettering in August 2010, we were anticipating a financial impact of roughly $225,000 in the first year so we are incredibly pleased with the $3.7 million results," said Dennis Grimaud, Chairman and CEO of DIATHERIX Inc. "Our technology has been so successful at Kettering because the administration, physicians, scientists, nurses and pharmacists all embraced this innovation and were open to change. As a result, they have experienced a dramatic improvement in patient outcomes and utilization of hospital resources." (Click here for a video for more information).
The DIATHERIX test takes about six hours to perform, compared to conventional technology requiring a minimum of 48 hours, which has had an enormous impact on the management of patients.
Source: DIATHERIX Laboratories Inc
